Related Experiment Video
Updated: Aug 5, 2026

DNAzyme 10-23 - Based Nanomachines for Nucleic Acid Recognition
Published on: February 9, 2024
Physicochemical developability insights into human Fab fragments with extended hypervariable loops
Marcel Passon1, Gianluca Bandera2, Leonard Mayerhöfer2
1Faculty of Pharmaceutical Sciences, Ghent University, Ottergemsesteenweg 460, 9000, Ghent, Belgium; Biopharmaceutical Technology, TUM School of Life Sciences, Technical University of Munich, Emil-Erlenmeyer-Forum 5, 85354 Freising, Germany.
Human antibodies with extended complementarity-determining regions (CDRs) offer therapeutic potential but face developability challenges. Analysis reveals sequence-dependent features, not just length, influence antibody liabilities, guiding development strategies.
Area of Science:
- Biochemistry
- Immunology
- Pharmaceutical Science
Background:
- Human antibodies with extended complementarity-determining regions (CDRs) present unique therapeutic opportunities for targeting challenging molecules.
- However, the developability of these antibodies for pharmaceutical applications can be hindered by potential issues.
Purpose of the Study:
- To analyze the developability of human antibody fragments (Fabs) with extended CDR-H3s.
- To identify sequence-dependent features and liabilities associated with long CDR-H3s.
- To inform mechanistically guided strategies for antibody drug development.
Main Methods:
- Integrated experimental and computational workflows were employed.
- Five human Fabs with long CDR-H3s were assessed for secretion, homogeneity, conformational and colloidal stability, and non-specific binding.
- Molecular dynamics simulations were used to probe conformational dynamics and interpret experimental findings.
Main Results:
- Extended CDR-H3s exhibit general sequence-dependent characteristics and liabilities.
- These features are not solely determined by the length of the CDR-H3.
- Experimental and computational analyses provided insights into the underlying mechanisms.
Conclusions:
- Developability of human antibodies with extended CDR-H3s is influenced by specific amino acid sequences.
- A mechanistically informed development strategy is crucial for optimizing these therapeutic candidates.
- This research aids in overcoming challenges in developing antibodies with enhanced binding capabilities.
Related Concept Videos
Conserved Binding Sites
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally analyses the...
Maxam-Gilbert Sequencing
Challenges of the Maxam-Gilbert Method
The...
Conservation of Protein Domains Over Different Proteins
A limited set of protein domains often duplicate and recombine during evolution. These domains can be organized in different combinations to form...
Long-patch Base Excision Repair
Homologous Recombination
Globular and Fibrous Proteins
Globular proteins are also known as spheroproteins and typically are approximately round in shape. They contain a mix of amino acid types and contain differing sequences in their primary structures. Globular proteins have many different functions, such as enzymes, cellular messengers, and molecular transporters. These roles often require the proteins to be...
